• Eyenovia to Participate in Two Upcoming Investor Conferences

    المصدر: Nasdaq GlobeNewswire / 07 يوليو 2021 16:01:00   America/New_York

    NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP™) platform technology, today announced that management will present a corporate overview and host one-one-one meetings at the Ladenburg Thalmann 2021 Healthcare Conference, being held virtually July 13-14, 2021, and host one-on-meetings at the William Blair Biotech Focus Conference 2021, being held virtually July 14-15, 2021.

    Details of the Ladenburg presentation are below:

    Date:Wednesday, July 14, 2021
    Time:9:00AM Eastern Time
    Webcast:https://wsw.com/webcast/ladenburg7/eyen/2421499

    About Eyenovia, Inc.

    Eyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. For more information, visit www.eyenovia.com.

    The Eyenovia Corporate Information slide deck may be found at ir.eyenovia.com/events-and-presentations.

    Eyenovia Contact:
    Eyenovia, Inc.
    John Gandolfo
    Chief Financial Officer
    jgandolfo@eyenovia.com

    Eyenovia Investor Contact:
    Eric Ribner
    LifeSci Advisors, LLC
    eric@lifesciadvisors.com
    (646) 751-4363

    Eyenovia Media Contact:
    Sam Choinski
    Pazanga Health Communications
    schoinski@pazangahealth.com
    (603) 489-5964


    Primary Logo

شارك على،